GCP-Certified Site
Good Clinical Practice certification granted by INVIMA in 2024 under Resolution 2378 of 2008, on top of an IPS licence issued by the Colombian Ministry of Health in 2022. Authorised to run Phase I, II, III and IV clinical studies, and holding an active Federalwide Assurance (FWA) with the U.S. Office for Human Research Protections (OHRP).












